Association of pharmacogenomic, clinical and behavioural factors with oral levothyroxine (LT-4) dose of hypothyroid patients in Sri Lanka: a matched case control study
Abstract Background Hypothyroidism is a common endocrine disorder that exerts a substantial influence on people all over the world. Levothyroxine (LT-4) is the drug of choice for the treatment of hypothyroidism and the starting oral dose is typically ranging from 1.5 to 1.7 µg/kg/day. The target is...
Saved in:
Main Authors: | S. S. Dalugodage (Author), Gayan Bowatte (Author), Charles Antonypillai (Author), S. Rajapakse (Author), T. M. I. U. K. Tennakoon (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypothyroid Symptoms in Levothyroxine-Treated Patients
by: Maisha Freeman, et al.
Published: (2019) -
Does it need administer extra-low dose levothyroxine supplementation to infertile women with subclinical hypothyroidism?
by: Wen-Ling Lee, et al.
Published: (2024) -
P-glycoprotein polymorphism and levothyroxine bioavailability in hypothyroid patients
by: Ezgi Öztaş, et al.
Published: (2018) -
Healthcare seeking behaviour among female garment workers in Koggala Free Trade Zone, Sri Lanka
by: Sanjeeva Rajapakse, et al.
Published: (2018) -
Recalibration of Framingham risk for a local population of Sri Lanka
by: Sameera Upashantha Ranasinghe, et al.
Published: (2024)